AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
Completed
- Conditions
- Patients With Upper Gastro-intestinal Symptoms
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2014-10-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3170
- Registration Number
- NCT01635959
- Locations
- 🇪🇬
Research Site, Tanta, Egypt
A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 18
- Registration Number
- NCT01635985
A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: AZD6244 Dosing Period 1Drug: AZD6244 Dosing Period 2Drug: AZD6244 Dosing Period 3Drug: AZD6244 Dosing Period 4
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 27
- Registration Number
- NCT01635023
- Locations
- 🇺🇸
Reseatch Site, Overland Park, Kansas, United States
CorRELation Between PatIent PErception and Findings on Clinical Examination
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2012-06-26
- Last Posted Date
- 2013-02-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 505
- Registration Number
- NCT01627743
- Locations
- 🇷🇴
Research Site, Slatina, Romania
Observational Study to Understand Patients' and Physicians' Attitudes to Statins in TurkeY
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2012-06-22
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 500
- Registration Number
- NCT01625884
- Locations
- 🇹🇷
Research Site, Manisa, Turkey
🇹🇷Research name, Aydin, Turkey
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients
Phase 1
Completed
- Conditions
- Advanced or Metastatic Breast CancerER+ve Advanced or Metastatic Breast Cancer
- Interventions
- Drug: AZD5363 when combined with weekly paclitaxel.Drug: AZD5363when combined with weekly paclitaxel.Drug: A placebo in combination with weekly paclitaxel.
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 148
- Registration Number
- NCT01625286
- Locations
- 🇬🇧
Research Site, Sutton, United Kingdom
Asthma Comparative Effectiveness Study
Completed
- Conditions
- Asthma
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6086
- Registration Number
- NCT01623544
Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 42
- Registration Number
- NCT01623609
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Phase 3
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- First Posted Date
- 2012-06-14
- Last Posted Date
- 2016-04-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 315
- Registration Number
- NCT01619059
- Locations
- 🇺🇸
Beach Physicians Clinical Research Corp., Huntington Beach, California, United States
🇺🇸Torrance Clinical Research, Lomita, California, United States
🇺🇸Cassidy Medical Group/Clinical Research Advantage, Vista, California, United States
An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and Lebanon
Completed
- Conditions
- High Blood Cholesterol
- First Posted Date
- 2012-06-08
- Last Posted Date
- 2012-06-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1000
- Registration Number
- NCT01614561